Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 9–9 | Cite as

Palbociclib plus endocrine therapy: no cumulative risks of AEs

Clinical study
  • 21 Downloads

Reference

  1. Dieras V, et al. Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. Journal of the National Cancer Institute : 18 Jul 2018. Available from: URL: http://doi.org/10.1093/jnci/djy109

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations